Please use this identifier to cite or link to this item:
https://scholarbank.nus.edu.sg/handle/10635/170794
Title: | POPULATION SOURCED DISCOVERY OF GENETIC VARIANTS IN STATIN METABOLISM | Authors: | YEE WEI LOONG SHERMAN | Keywords: | Pharmacogenetics, Statins, Pharmacokinetics, Genome-wide Association, UGT1A1, Drug and Metabolite Ratios | Issue Date: | 20-Jan-2020 | Citation: | YEE WEI LOONG SHERMAN (2020-01-20). POPULATION SOURCED DISCOVERY OF GENETIC VARIANTS IN STATIN METABOLISM. ScholarBank@NUS Repository. | Abstract: | 3-hydroxy-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, or statins, are one of the most prescribed drugs for the prevention of cardiovascular disease and act by reducing plasma low-density lipoprotein (LDL) cholesterol. In Singapore, 47% of adult patients use either atorvastatin or simvastatin. Statin medications are known for their various lipid independent effects and these effects can contribute to clinical decision making regarding the prescription of statins. As a whole, this thesis demonstrates the robustness of the two-time point blood draw protocol as a novel method to evaluate drug pharmacokinetics through time normalisation. The knowledge presented also provides a foundation for future clinical studies and clinical trials that look to explore variability in drug concentrations and their ratios in patient populations to evaluate potential differences in drug metabolism as well as the use of drug and drug metabolite concentrations as potential outcomes in future pharmacogenomic studies. | URI: | https://scholarbank.nus.edu.sg/handle/10635/170794 |
Appears in Collections: | Ph.D Theses (Open) |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
YeeWLS.pdf | 5.94 MB | Adobe PDF | OPEN | None | View/Download |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.